Every Form 4 that CareDx, Inc. (CDNA) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A Form 4 covers the transactions officers, directors and large holders report, so if you follow CDNA and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full CDNA filings page.
CareDx, Inc. President and CEO John Walter Hanna Jr. reported a sale of company stock. On January 15, 2026, he sold 10,156 shares of CareDx common stock in an open-market transaction coded as a sale. The shares were sold at a weighted average price of $21.052 per share, with individual trade prices ranging from $21.00 to $21.18.
The sale was carried out under a pre-arranged Rule 10b5-1 trading plan that he adopted on December 13, 2024, which is designed to allow insiders to sell shares according to a preset schedule. After this transaction, he beneficially owned 616,885 shares of CareDx common stock directly.
CareDx, Inc. director Michael Goldberg reported receiving an automatic quarterly grant of common stock as part of his non-employee director compensation. On January 6, 2026, he was awarded 1,492 shares of CareDx common stock at a reported price of $0 per share, reflecting equity paid in lieu of cash fees under the company’s Outside Director Compensation Policy. Following this grant, he beneficially owned 157,461 shares of CareDx common stock held directly.
CareDx (CDNA): The company’s Secretary and General Counsel reported an open-market sale of common stock. On 11/07/2025, the insider sold 2,688 shares at an average price of $15.5219 (code S). Following the transaction, the insider beneficially owns 105,218 shares, held directly. The sale was executed under a Rule 10b5-1 trading plan adopted on September 4, 2025.
CareDx (CDNA) insider filing: The company’s Secretary and General Counsel reported an automatic share withholding tied to restricted stock unit vesting. On 11/06/2025, 2,152 shares of common stock were withheld at $15.01 under transaction code F to satisfy tax obligations, as stated in the footnote. Following this administrative transaction, the insider beneficially owns 107,906 shares, held directly.
CareDx, Inc. (CDNA) reported an insider Form 4 for its Secretary and General Counsel. On 11/01/2025, an F-code transaction reflected 2,872 shares withheld to cover taxes upon RSU vesting at a price of $14.77 per share. Following the transaction, the officer beneficially owns 110,058 shares, held directly.
The filing notes the shares were withheld by the issuer to satisfy tax withholding obligations tied to vested restricted stock units.
CareDx (CDNA) reported a director equity award. On 10/22/2025, the reporting person acquired 27,453 shares of Common Stock, labeled as an acquisition at a price of $0.
The award is represented by restricted stock units (RSUs) that vest in equal annual installments, with 100% vested on the third anniversary of October 22, 2025, subject to continued service. Each RSU represents the right to receive 1 share of Common Stock upon settlement for no consideration. Following the reported transaction, the reporting person beneficially owned 27,453 shares directly.